Several retrospective studies suggested that risk-reducing bilateral salpingo-oophorectomy (RRBSO) is associated with reduction in risk not only for ovarian and fallopian tube cancer, but also for breast cancer in BRCA1/2 mutation carriers (Rebbeck et al. 2009; Domchek et al. 2010). This evidence concerns the gene BRCA1 and breast carcinoma.